Title
|
Site PI/Sponsor
|
Transition of Care for Patients with VTE
|
Dr. Henny Billett
ATHN
|
CDC Public Health Surveillance for Bleeding Disorders
|
Dr. Henny Billett
CDC
|
My Life Our Future: A Hemophilia Genotyping Initiative
|
Dr. Henny Billett
ATHN
|
A Two-Part Study of UBS Point-of-Care PT/INR System with Focus on High INR Capillary and Venous Samples
|
Dr. Henny Billett
Dr. Margarita Kushnir
Universal Biosystems
|
Efficacy & Safety of Rivaroxaban Prophylaxis in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for VTE
|
Dr. Henny Billett
Dr. Margarita Kushnir
Janssen Pharmaceuticals
|
Apixaban For The Treatment of Venous Thromboembolism in Patients with Cancer: A Prospective randomized open Blinded end-point (PROBE) Study - The Caravaggio Study
|
Dr. Henny Billett
Dr. Margarita Kushnir
|
Evaluation of Inflammatory Markers and Opiorphin Levels in Sickle Cell Anemia
|
Dr. Kevin Davies
Dr. Henny Billett (Co-I)
|
IRON CLAD: Can Iron Lessen Anemia Due to cancer & chemotherapy: A multi-center, randomized, double-blinded, controlled study to investigate the efficacy and safety of Injectafer® (ferric carboxymaltose injection).
|
Dr. Mark Chaitowitz
Luitpold
|
Open-label Study to Assess the Long-term Safety and Efficacy of Momelotinib in Subjects with Primary MF, Post-PV MF, Post-ET MF, PV or ET
|
Dr. Swati Goel
|
A Double-Blind, Double-Dummy Phase 2 Randomized Study to Evaluate the Efficacy and Safety of Ruxolitinib Versus Anagrelide in Subjects with Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea
|
Dr. Swati Goel
INCB
|
A Phase 2 Study of the Safety, Tolerability, and Efficacy of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis
|
Dr. Swati Goel
INCB
|
Outcomes in Patients with Polycythemia Vera treated with Ruxolitinib for Hydroxyurea Refractory Disease
|
Dr. Swati Goel
|
A Phase 3, Randomized, Open-label, Active Controlled Study
of ALXN1210 Versus Eculizumab in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated with Eculizumab
|
Dr. Irina Murakhovskaya Alexion
|
Single arm study of ALXN1210 in complement inhibitor
Treatment-naïve adult and adolescent patients with
Atypical hemolytic uremic syndrome (aHUS)
|
Dr. Irina Murakhovskaya Alexion
|
A Phase 2, Multi-Center, Open Label, Simon Two-Stage Study to Evaluate the Safety and Efficacy of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia
|
Dr. Irina Murakhovskaya
Rigel
|
Prospective, non-interventional study of disease
Progression and treatment of patients with polycythemia Vera in United States academic or community clinical practices
|
Dr. Ellen Friedman
Incyte
|
Nitrite Cream for leg ulcers: Phase II trial of topical sodium nitrite in patients with sickle cell disease and leg ulcers
|
RO1. FDA
Dr. Caterina Minniti
Dr. Ugochi Ogu
|
14-HG-0125: Insights into the Skin Microbiome and Environmental Contributions to Health and Formation of Leg Ulcers in Individuals Living with Sickle Cell Disease
|
NHGRI
Dr. Caterina Minniti
Dr. Ugochi Ogu
|
GBT 440-031: A Phase 3, Double-blind, Randomized, Placebo-controlled, Multicenter Study of GBT440 Administered Orally to Patients With Sickle Cell Disease
|
Dr. Caterina Minniti
Dr. Ugochi Ogu
|
1503 BMT CTN: Bone Marrow Transplantation in Young Adults With Severe Sickle Cell Disease
|
Dr. Caterina Minniti
Dr. Ugochi Ogu
|
Characterization of Hemopoiesis in Hemoglobinopathies
|
Dr. Eric Bouhassirra
Dr. Caterina Minniti
|
Study to Assess the Safety, Tolerability, and Efficacy of Riociguat in Patients with Sickle Cell Diseases
|
Dr. Caterina Minniti
Dr. Ugochi Ogu
|
Tailored Self-Administered Mindfulness
Body scan in chronic pain at a Sickle Cell
Clinic and effects on pain and acute
Health Care Utilization
|
Dr. Caterina Minniti
Dr. Cristian Zanartu
|
